Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial dynamic network maintenance
- Molecular classification
- Other
01
Overview
Mitochondrial dynamic network maintenance refers to the continuous balancing of mitochondrial fission, fusion, mitophagy, and transport processes that govern the structure, quality, and function of the mitochondrial network within cells[2][4]. These dynamics are primarily regulated by a set of highly conserved proteins: mitofusins 1 and 2 mediate outer membrane fusion, OPA1 governs inner membrane fusion, and Drp1 controls mitochondrial fission. Loss of function or dysregulation of these proteins is implicated in diverse diseases, reflecting the essential role of mitochondrial dynamics in cellular metabolism, apoptosis, development, and calcium signaling. As it is a process, not a single protein, this term should not be used as a molecular drug target, but its component proteins are valid therapeutic targets in related pathologies[1][2][3][4].
- Other names
- Mitochondrial dynamicsMitochondrial fission and fusionMitochondrial network maintenance
02
Mechanism of action
Inhibition or activation of fission (e.g., via Drp1 modulation) Promotion or blockade of fusion (e.g., via mitofusin or OPA1 modulation)
03
Biological functions
Maintenance of mitochondrial morphologyApoptosis regulationQuality control (mitophagy)Signal transductionCell cycle progressionCellular metabolism and energy homeostasis
04
Disease associations
Neurodegenerative diseaseCancerCardiovascular diseaseMetabolic diseaseOther
05
Safety considerations
Modulation of mitochondrial dynamics may impact essential cellular functions, leading to cell death or compromised energy metabolism; specificity is a critical therapeutic challenge
06
Interacting drugs
Indirectly, agents such as mdivi-1 (Drp1 inhibitor), or compounds that modulate mitofusin activity have been used to alter mitochondrial dynamics in models, but no drugs directly target "mitochondrial dynamic network maintenance" as a singular entity
07
Biomarkers
Expression and post-translational state of Drp1, mitofusin 1 and 2, OPA1Mitochondrial morphology (fragmented vs. interconnected networks) assessed via imaging
Beyond the preview
Go deeper on Mitochondrial dynamic network maintenance.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitochondrial dynamic network maintenance.